Missed Out on Eli Lilly? 2 Healthcare Stocks With Big Catalysts on the Horizon.
Eli Lilly’s (NYSE: LLY) stock has risen 225% over the past three years. That trounces the S&P 500’s (SNPINDEX:…
Eli Lilly Soared by 39% in 2025, but Here’s Another Healthcare Stock to Buy in 2026
Eli Lilly’s (NYSE: LLY) share price jumped 39% in 2025, driven by investors eager to benefit from the…
The AI Stocks That Insiders Are Loading Up on for 2026
There hasn’t been a lot of insider buying from executives and directors at artificial intelligence (AI) companies recently,…
Strong Theater Demand Drives IMAX Corporation (IMAX) Stock Momentum
Orbis Investment Management released its Q4 2025 investor letter for “Orbis SICAV International Equity Fund”. The Strategy reported…
This “Picks and Shovels” Data Streaming Stock Looks Built for Long‑Term AI Upside
BigBear.ai has stumbled since its market debut. It’s struggling to expand beyond its niche government market. IBM’s scale…
New Found Gold Corp. (NFGC) Transitions into Emerging Canadian Gold Producer
New Found Gold Corp (NYSE: NFGC) is one of the best debt-free penny stocks to buy right now.…
Live updates: Wall Street bounces to record despite disappointing jobs data, ASX set to rise
Wall Street’s key S&P 500 index gained another 0.6% to propel it to yet another record close, little…
The Overlooked Winners in the AI Gold Rush
The AI revolution is driving nearly insatiable demand for hardware like high-performance GPUs, CPUs, networking equipment, and storage.…
Got $1,000? 2 High-Yield Healthcare Stocks to Buy and Hold Forever
This drug company offers a decent balance of risk and reward, with a 4.6% yield and a payout…
Live markets updates: CBA reverses decision not to refund overcharged low-income customers
3h agoTue 23 Dec 2025 at 2:04amMarket snapshotASX 200: +0.9% to 8,780 pointsAustralian dollar: +0.1% to 66.62 US…
Live updates: Wall Street stumbles on tech sell-off, ASX set to fall
It wasn’t one of those champagne-popping, record-topping ends to the week on Wall Street. The bubbles went flat…
1 Major Factor Behind the Healthcare Sector’s Recent Surge
Eli Lilly’s GLP-1 drug became the world’s best-selling drug in Q3. Merck, Johnson & Johnson, AbbVie, and other…